Cargando…

c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients

Purpose: c-MYC has been noted in many tumor types, but its functional significance and clinical utility in oral squamous cell carcinoma (OSCC) are not well known. Here we studied the expression of c-MYC in correlation to clinical outcome in patients with oral squamous cell carcinoma. Methods: The cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shu-Hui, Wang, Hsin-Kai, Yeh, Kun-Tu, Tai, Hui-Chun, Wang, Hui-Yi, Huang, Lan-Ru, Chiu, Chun-Wen, Chung, Chia-Min, Velmurugan, Bharath Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556540/ https://www.ncbi.nlm.nih.gov/pubmed/31239771 http://dx.doi.org/10.2147/CMAR.S201943

Ejemplares similares

c-MYC expression in T (III/IV) stage oral squamous cell carcinoma (OSCC) patients [Corrigendum]
Publicado: (2019)

UNC13C Suppress Tumor Progression via Inhibiting EMT Pathway and Improves Survival in Oral Squamous Cell Carcinoma
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2019)

CIP2A overexpression in Taiwanese oral cancer patients
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2019)

C-MYC and BCL-2 mediate YAP-regulated tumorigenesis in OSCC
por: Chen, Xiyan, et al.
Publicado: (2017)

Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma
por: Chiang, Shang-Lun, et al.
Publicado: (2017)

miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)
por: Zhang, Hong-Yu, et al.
Publicado: (2020)

MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
por: Shao, Yuan, et al.
Publicado: (2013)

Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients
por: Velmurugan, Bharath Kumar, et al.
Publicado: (2016)

Secreted protein markers in oral squamous cell carcinoma (OSCC)
por: Mumtaz, Madiha, et al.
Publicado: (2022)

Therapeutic Perspectives for the Perioperative Period in Oral Squamous Cell Carcinoma (OSCC)
por: Galmiche, Antoine, et al.
Publicado: (2022)

Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC
por: Grimm, Martin, et al.
Publicado: (2015)

Epigenetic modulation of distal regulatory elements in oral squamous cell carcinoma (OSCC)
por: Wiench, Malgorzata, et al.
Publicado: (2013)

Advances of Salivary Proteomics in Oral Squamous Cell Carcinoma (OSCC) Detection: An Update
por: Sannam Khan, Rabia, et al.
Publicado: (2016)

MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
por: Shiiba, Masashi, et al.
Publicado: (2010)

Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes
por: Lohavanichbutr, Pawadee, et al.
Publicado: (2012)

Proline-Dependent Induction of Apoptosis in Oral Squamous Cell Carcinoma (OSCC)—The Effect of Celecoxib
por: Tołoczko-Iwaniuk, Natalia, et al.
Publicado: (2020)

Survival-Based Biomarker Module Identification Associated with Oral Squamous Cell Carcinoma (OSCC)
por: Singh, Prithvi, et al.
Publicado: (2021)

Methylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC)
por: Shojaeian, Sorour, et al.
Publicado: (2021)

ASC modulates HIF-1α stability and induces cell mobility in OSCC
por: Wu, Chi-Sheng, et al.
Publicado: (2020)

The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC
por: Wang, Lin-Hong, et al.
Publicado: (2018)

Impact of Polymorphisms in Casein Kinase 1 Epsilon and Environmental Factors in Oral Cancer Susceptibility
por: Lin, Shu-Hui, et al.
Publicado: (2019)

Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC)
por: Kim, Soo Yeon, et al.
Publicado: (2019)

The CS1 segment of fibronectin is involved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion
por: Kamarajan, Pachiyappan, et al.
Publicado: (2010)

Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells
por: Hung, Chih-Chang, et al.
Publicado: (2020)

7‐Epitaxol induces apoptosis in cisplatin‐resistant head and neck squamous cell carcinoma via suppression of AKT and MAPK signalling
por: Yang, Hui‐Ju, et al.
Publicado: (2022)

Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC)
por: Huang, Guang-zhao, et al.
Publicado: (2021)

Future Imaging Alternatives: The Clinical Non-invasive Modalities in Diagnosis of Oral Squamous Cell Carcinoma (OSCC)
por: Omar, Esam
Publicado: (2015)

MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc
por: Wang, Zuojun, et al.
Publicado: (2018)

Identification and preliminary study of a novel interacting protein SCRIB with fibroblast activation protein in OSCC: SCRIB interacts with fibroblast activation protein in OSCC
por: Liu, Shuyan, et al.
Publicado: (2023)

Breastfeeding and childhood cancer risks: OSCC data
por: Lancashire, R J, et al.
Publicado: (2003)

The Circular RNA-miRNA Axis: A Special RNA Signature Regulatory Transcriptome as a Potential Biomarker for OSCC
por: Saikishore, Ramanathan, et al.
Publicado: (2020)

Newly detected DNA viruses in juvenile nasopharyngeal angiofibroma (JNA) and oral and oropharyngeal squamous cell carcinoma (OSCC/OPSCC)
por: Dickinson, Amy, et al.
Publicado: (2018)

Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC)
por: Dong, Yan, et al.
Publicado: (2022)

Anti-Proliferative Effect of Statins Is Mediated by DNMT1 Inhibition and p21 Expression in OSCC Cells
por: Dongoran, Rachmad Anres, et al.
Publicado: (2020)

Survival and associated factors among patients with oral squamous cell carcinoma (OSCC) in Mulago hospital, Kampala, Uganda
por: Asio, Juliet, et al.
Publicado: (2018)

Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population
por: Goel, Harsh, et al.
Publicado: (2020)

Screening and identification of autophagy‐related biomarkers for oral squamous cell carcinoma (OSCC) via integrated bioinformatics analysis
por: Huang, Guang‐zhao, et al.
Publicado: (2021)

Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population
por: Goel, Harsh, et al.
Publicado: (2021)

Oral Squamous Cell Carcinoma (OSCC) Imitates Denosumab-Induced Osteonecrosis of the Mandibular Alveolus: A Diagnostic Challenge
por: Zisis, Vasileios, et al.
Publicado: (2023)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kqi2l1dirdu3cfe8grc7bvleki